You spelled Nasch wrong. CytodynE is bringing Lauronlimab to market for Nasch not Nash. But I'm just posting legitimate information and questions because I'm a legitimate lawnge so what do I know?

And for those that need to hear it, we all need to realize that while conferences are beneficial when you're presenting great information, which I believe we will be, they aren't instant catalysts that will light our share price on fire. I keep seeing posts across boards acting like it's t-minus X number of days until launch. It's almost as frustrating as people not learning how to spell Cytodyn. Or purposely adding the E, of course.